25 items of Pfizer Korea are subject to suspension of manufacturing business

In line with the recent controversy on the mixed packaging of both Cardura(doxazosin mesylate) and Cofrel (benproperine phosphate), 25 items of Pfizer Korea including Norvasc (amlodipine besylate) will subject to the prior notice for administrative disposition.

In its notice to Pfizer Korea on August 19, the KFDA said that 25 items in the form of tablet and capsule, which have been produced ...